Bivision Pharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Bivision Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer (NCT06139575) | Bivision Pharmaceuticals, Inc. | 2023-12-22 |
Track Bivision Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.